Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A growing population of people living with advanced or metastatic cancer has raised questions about the unique needs of these individuals.
An antibody-drug conjugate could be a step toward selective treatment for neuroendocrine prostate cancer.
Kari Kolstoe is finally home but still can’t get treatment for her advanced neuroendocrine cancer.
Here’s what to know about neuroendocrine tumor, the rare pancreas cancer that claimed the life of the Queen of Soul.
The renowned singer died of a neuroendocrine tumor in the pancreas.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.